Hiroshi KOKUBU, PhD

Principal Scientist
K Pharma, Inc., Japan

Poster(s):

• (W1339) IN VITRO DISEASE MODELING OF FTLD USING PATIENT-DERIVED IPSCS IDENTIFIED POTENTIAL THERAPEUTIC AGENTS AND CELLULAR/MOLECULAR MECHANISMS.
  Wednesday, June 11, 2025

  4:00 PM - 5:00 PM HK Time